Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Armstrong Pharmaceuticals, a subsidiary of Amphastar Pharmaceuticals, is a specialty pharmaceutical company based in Canton, Massachusetts, that focuses on the development and production of respiratory and inhalation therapies. The company is most notably recognized for manufacturing Primatene Mist, the only FDA-approved over-the-counter epinephrine inhaler for the temporary relief of symptoms associated with intermittent asthma. Armstrong specializes in complex manufacturing processes, particularly metered-dose inhalers (MDIs) and other inhalation drug delivery systems that require high precision and regulatory compliance. As a key manufacturing and R&D arm of Amphastar, the company supports a broader portfolio of emergency medications and specialty generics, including glucagon and epinephrine injections. Their expertise extends to handling specialized propellants and complex formulations for various respiratory conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Armstrong Healthcare.